Hormonal contraception and the risk of HIV acquisition

AIDS

Volumn 21, Issue 1, 2007, Pages 85-95

  Morrison, Charles S ^a,k   Richardson, Barbra A ^b   Mmiro, Francis ^d   Chipato, Tsungai ^e   Celentano, David D ^f   Luoto, Joanne ^g   Mugerwa, Roy ^d   Padian, Nancy ^h   Rugpao, Sungwal ⁱ   Brown, Joelle M ^h   Cornelisse, Peter ^c   Salata, Robert A ^j  

^a FHI360   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c SEATTLE CHILDREN S RESEARCH INSTITUTE   (United States)

^d MAKERERE UNIVERSITY   (Uganda)

^e UNIVERSITY OF ZIMBABWE   (Zimbabwe)

^f JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^g EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^h UNIVERSITY OF CALIFORNIA   (United States)

ⁱ CHIANG MAI UNIVERSITY   (Thailand)

^j CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^k FAMILY HEALTH INTERNATIONAL   (United States)

more..

Author keywords

Depo provera; Herpes virus; Heterosexual transmission; HIV acquisition; Hormonal contraception; Oral contraceptives; Women

Indexed keywords

MEDROXYPROGESTERONE ACETATE;

ADULT; ARTICLE; CONTROLLED STUDY; FAMILY PLANNING; FEMALE; FOLLOW UP; HERPES SIMPLEX VIRUS 2; HORMONAL CONTRACEPTION; HUMAN; HUMAN EXPERIMENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INFECTION RISK; ORAL CONTRACEPTION; PRIORITY JOURNAL; SCREENING TEST; SEXUALLY TRANSMITTED DISEASE; THAILAND; UGANDA; ZIMBABWE;

ADULT; CONFIDENCE INTERVALS; CONTRACEPTION BEHAVIOR; CONTRACEPTIVES, ORAL, HORMONAL; DELAYED-ACTION PREPARATIONS; DISEASE TRANSMISSION, HORIZONTAL; FEMALE; HERPES SIMPLEX; HERPESVIRUS 2, HUMAN; HIV; HIV INFECTIONS; HUMANS; MALE; MEDROXYPROGESTERONE 17-ACETATE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK; THAILAND; UGANDA; ZIMBABWE;

EID: 33845486100     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAD.0b013e3280117c8b     Document Type: Article

References (39)

1. Population Reference Bureau. Family Planning Worldwide 2002 Data Sheet. Washington, DC: Population Reference Bureau; 2002.
2. Uganda Bureau of Statistics and Macro International. Uganda Demographic and Health Survey 2000-2001. Calverton, MD: Uganda Bureau of Statistics and Macro International; 2001.
3. Central Statistical Office (Zimbabwe) and Macro International. Zimbabwe Demographic and Health Survey 1999. Calverton, MD: Central Statistical Office and Macro International; 2000.
4. Central Bureau of Statistics. Kenya Demographic and Health Survey 2003, Preliminary Report. Nairobi: Central Bureau of Statistics, Ministry of Planning and National Development; 2003.
5. UNAIDS. 2005 Report on the Global AIDS Epidemic, Executive Summary. Geneva: Joint United Nations Programme on HIV/AIDS (UNAIDS); 2005.
6. Plourde PJ, Pepin J, Agoki E, Ronald AR, Ombette J, Tyndall M, et al. Human immunodeficiency virus type 1 seroconversion in women with genital ulcers. J Infect Dis 1994; 170:313-317.
7. Plummer FA, Simonsen JN, Cameron DW, Ndinya-Achola JO, Kreiss JK, Gakinya MN, et al. Cofactors in male-female sexual transmission of human immunodeficiency virus type 1. J Infect Dis 1991; 163:233-239.
8. Saracco A, Musicco M, Nicolosi A, Angarano G, Arici C, Gavazzeni G, et al. Man-to-woman sexual transmission of HIV: longitudinal study of 343 steady partners of infected men. J Acquir Immune Defic Syndr 1993; 6:497-502.
9. Laga M, Manoka A, Kivuvu M, Malele B, Tuliza M, Nzila N, et al. Non-ulcerative sexually transmitted diseases as risk factors for HIV-1 transmission in women: results from a cohort study. AIDS 1993; 7:95-102.
10. de Vincenzi I. A longitudinal study of human immunodeficiency virus transmission by heterosexual partners. European Study Group on Heterosexual Transmission of HIV. N Engl J Med 1994; 331:341-346.
11. Ungchusak K, Rehle T, Thammapornpilap P, Spiegelman D, Brinkmann U, Siraprapasiri T. Determinants of HIV infection among female commercial sex workers in northeastern Thailand: results from a longitudinal study. J Acquir Immune Defic Syndr Hum Retrovirol 1996; 12:500-507.
12. Sinei SK, Fortney JA, Kigondu CS, Feldblum PJ, Kuyoh M, Allen MY, et al. Contraceptive use and HIV infection in Kenyan family planning clinic attenders. Int J STD AIDS 1996; 7:65-70.
13. Kilmarx PH, Limpakarnjanarat K, Mastro TD, Saisorn S, Kaewkungwal J, Korattana S, et al. HIV-1 seroconversion in a prospective study of female sex workers in northern Thailand: continued high incidence among brothel-based women. AIDS 1998; 12:1889-1898.
14. Kapiga SH, Lyamuya EF, Lwihula GK, Hunter DJ. The incidence of HIV infection among women using family planning methods in Dar es Salaam, Tanzania. AIDS 1998; 12:75-84.
15. Martin HL Jr, Nyange PM, Richardson BA, Lavreys L, Mandaliya K, Jackson DJ, et al. Hormonal contraception, sexually transmitted diseases, and risk of heterosexual transmission of human immunodeficiency virus type 1. J Infect Dis 1998; 178:1053-1059.
16. Kiddugavu M, Makumbi F, Wawer MJ, Serwadda D, Sewankambo NK, Wabwire-Mangen F, et al. Hormonal contraceptive use and HIV-1 infection in a population-based cohort in Rakai, Uganda. AIDS 2003; 17:233-240.
17. Lavreys L, Baeten JM, Martin HL Jr, Overbaugh J, Mandaliya K, Ndinya-Achola J, et al. Hormonal contraception and risk of HIV-1 acquisition: results of a 10-year prospective study. AIDS 2004; 18:695-697.
18. Bulterys M, Chao A, Habimana P, Dushimimana A, Nawrocki P, Saah A. Incident HIV-1 infection in a cohort of young women in Butare, Rwanda. AIDS 1994; 8:1585-1591.
19. Wang CC, Reilly M, Kreiss JK. Risk of HIV infection in oral contraceptive pill users: a meta-analysis. J Acquir Immune Defic Syndr 1999; 21:51-58.
20. Stephenson JM. Systematic review of hormonal contraception and risk of HIV transmission: when to resist meta-analysis. AIDS 1998; 12:545-553.
21. Bracken MB, Hellenbrand KG, Holford TR. Conception delay after oral contraceptive use: the effect of estrogen dose. Fertil Steril 1990; 53:21-27.
22. Pardthaisong T, Gray RH, McDaniel EB. Return of fertility after discontinuation of depot medroxyprogesterone acetate and intra-uterine devices in Northern Thailand. Lancet 1980; i:509-512.
23. Cassol S, Salas T, Gill MJ, Montpetit M, Rudnik J, Sy CT, et al. Stability of dried blood spot specimens for detection of human immunodeficiency virus DNA by polymerase chain reaction. J Clin Microbiol 1992; 30:3039-3042.
24. Ashley-Morrow R, Krantz E, Wald A. Time course of seroconversion by HerpeSelect ELISA after acquisition of genital herpes simplex virus type 1 (HSV-1) or HSV-2. Sex Transm Dis 2003; 30:310-314.
25. Schwebke JR, Hillier SL, Sobel JD, McGregor JA, Sweet RL. Validity of the vaginal gram stain for the diagnosis of bacterial vaginosis. Obstet Gynecol 1996; 88:573-576.
26. Research Triangle Institute. SUDAAN User's Manual, Release 8.0. Research Triangle Park, NC: Research Triangle Institute; 2002.
27. Alioum A, Dabis F, Dequae-Merchadou L, Haverkamp G, Hudgens M, Hughes J, et al. Estimating the efficacy of interventions to prevent mother-to-child transmission of HIV in breast-feeding populations: development of a consensus methodology. Stat Med 2001; 20:3539-3556.
28. Morrison CS, Bright P, Wong EL, Kwok C, Yacobson I, Gaydos CA, et al. Hormonal contraceptive use, cervical ectopy, and the acquisition of cervical infections. Sex Transm Dis 2004; 31:561-567.
29. Louv WC, Austin H, Perlman J, Alexander WJ. Oral contraceptive use and the risk of chlamydial and gonococcal infections. Am J Obstet Gynecol 1989; 160:396-402.
30. Bright PL. A longitudinal investigation of cervical ectopy. Thesis, University of North Carolina at Chapel Hill, 2003 (UMI Disertation Services 3086503).
31. Baeten JM, Nyange PM, Richardson BA, Lavreys L, Chohan B, Martin HL Jr, et al. Hormonal contraception and risk of sexually transmitted disease acquisition: results from a prospective study. Am J Obstet Gynecol 2001; 185:380-385.
32. Miller L, Patton DL, Meier A, Thwin SS, Hooton TM, Eschenbach DA. Depomedroxyprogesterone-induced hypoestrogenism and changes in vaginal flora and epithelium. Obstet Gynecol 2000; 96:431-439.
33. Mauck CK, Callahan MM, Baker J, Arbogast K, Veazey R, Stock R, et al. The effect of one injection of depo-provera on the human vaginal epithelium and cervical ectopy. Contraception 1999; 60:15-24.
34. Sonnex C. Influence of ovarian hormones on urogenital infection. Sex Transm Infect 1998; 74:11-19.
35. 239. J Infect Dis 2004; 190:1697-1705.
36. Prakash M, Kapembwa MS, Gotch F, Patterson S. Oral contraceptive use induces upregulation of the CCR5 chemokine receptor on CD4(R) T cells in the cervical epithelium of healthy women. J Reprod Immunol 2002; 54:117-131.
37. Ghanem KG, Shah N, Klein RS, Mayer KH, Sobel JD, Warren DL, et al. Influence of sex hormones, HIV status, and concomitant sexually transmitted infection on cervicovaginal inflammation. J Infect Dis 2005; 191:358-366.
38. Morrison CS, Kwok C, Demers K, Lovvorn A, Chipato T, Mmiro F, et al. Predictors of CD4 decline in women with incident HIV-1 infection in east and southern Africa. 11th Conference on Retroviruses and Opportunistic Infections. San Francisco, February 2004 [abstract 950].
39. Pariani S, Heer DM, Van Arsdol MD Jr. Does choice make a difference to contraceptive use? Evidence from east Java. Stud Fam Plann 1991; 22:384-390.